LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 92.25 27.76 6952 6873 1.0115 1.0029
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 93.96 27.76 785 6849 0.1146 0.5228
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 93.96 27.76 5878 6849 0.8582 0.9619
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 93.96 27.76 33 6849 0.0048 0.0220
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 93.96 27.76 2580 6849 0.3767 0.7688
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 93.96 27.76 721 6849 0.1053 0.5066
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 93.96 27.76 7188 6849 1.0495 1.0122
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 95.66 27.76 809 6712 0.1205 0.5310
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 95.66 27.76 6143 6712 0.9151 0.9777
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 95.66 27.76 11 6712 0.0016 -0.1103
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 95.66 27.76 2426 6712 0.3614 0.7588
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 95.66 27.76 783 6712 0.1167 0.5247
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 95.66 27.76 7484 6712 1.1149 1.0277
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.0056667
 1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 1.95 27.76 643 225 2.8560 1.8311
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 1.95 27.76 674 225 2.9937 1.8756
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 3.66 27.76 1 283 0.0035 -0.6287
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 3.66 27.76 758 283 2.6697 1.6802
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 3.66 27.76 1 283 0.0035 -0.6287
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 3.66 27.76 768 283 2.7049 1.6906
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 5.36 27.76 848 320 2.6470 1.6353
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 5.36 27.76 862 320 2.6907 1.6476
MN20160318_Q01
N13